State-Dependent Inhibition of Nav1.8 Sodium Channels by VX-150 and VX-548
Molecular Pharmacology · 2024
DOI: 10.1124/molpharm.124.000944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2024. Verfasst von Patric Vaelli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology (P.V., A.F., S.J., H.-X.B.Z., T.O., B.P.B.) and Laboratory of Systems Pharmacology and Harvard Program in Therapeutics (X.…. Hauptthemen laut MEDLINE: NAV1.8 Voltage-Gated Sodium Channel. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology (P.V., A.F., S.J., H.-X.B.Z., T.O., B.P.B.) and Laboratory of Systems Pharmacology and Harvard Program in Therapeutics (X.M.), Harvard Medical School, Boston, Massachusetts.
- Department of Neurobiology (P.V., A.F., S.J., H.-X.B.Z., T.O., B.P.B.) and Laboratory of Systems Pharmacology and Harvard Program in Therapeutics (X.M.), Harvard Medical School, Boston, Massachusetts bruce_bean@hms.harv…
ORCID-Profile: Sooyeon Jo
Förderung
- NINDS NIH HHS
Zitieren
APA
Vaelli, P., Fujita, A., Jo, S., Zhang, H. B., Osorno, T., Ma, X., & Bean, B. P. (2024). State-Dependent Inhibition of Nav1.8 Sodium Channels by VX-150 and VX-548. Molecular Pharmacology. https://doi.org/10.1124/molpharm.124.000944
Vancouver
Vaelli P, Fujita A, Jo S, Zhang HB, Osorno T, Ma X, et al. State-Dependent Inhibition of Nav1.8 Sodium Channels by VX-150 and VX-548. Molecular Pharmacology. 2024. doi:10.1124/molpharm.124.000944
BibTeX
@article{Vaelli2024,
author = {Vaelli, Patric and Fujita, Akie and Jo, Sooyeon and Zhang, Han-Xiong Bear and Osorno, Tomás and Ma, Xiao and Bean, Bruce P},
title = {State-Dependent Inhibition of Nav1.8 Sodium Channels by VX-150 and VX-548},
journal = {Molecular Pharmacology},
year = {2024},
doi = {10.1124/molpharm.124.000944}
}
EUVIMED